MB02-DM

· mAbxience Research S.L.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MB02-DM, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing the Pharmacokinetic Similarity of MB02-SP, MB02-DM and US Licensed-Avastin®. [Phase 1]